Global Bioinformatics Market Size, Share, Trends and Growth Analysis Report – Segmented By Sector, Products & Services (Bioinformatics Platforms, Knowledge Management Tools and Bioinformatics Services), Application and Region - Industry Forecast (2024 to 2032)

Updated On: June, 2024
ID: 2912
Pages: 175

Global Bioinformatics Market Size (2024 to 2032)

As per our research analysis report, the global bioinformatics market is forecasted to be worth USD 77.21 billion by 2032 and USD 18.83 billion by 2024, growing at a CAGR of 19.29% during the forecast period.

Bioinformatics combines computer sciences, molecular biology, biotechnology, and statistics. It is a field of collecting, classifying, storing, and analyzing biological and biochemical information by using computer-based software tools. Genomics and proteomics are activities in that bioinformatics are used on a large scale. The field recently includes artificial intelligence and computer sciences for the development in the microbiology and genetic codes section. Additionally, several companies have expanded their innovation in gene expression, gene sequencing, and new drug discovery studies.

MARKET DRIVERS

Growing support and initiatives from the various governments and implementing new technologies are majorly propelling the growth of the global bioinformatics market.

The global bioinformatics market is expected to grow significantly by rising government initiatives and funding genomics-based R & D, increasing technology use in drug discovery and biomarker development. In addition, the gradual reduction of DNA sequencing costs is an essential driver of the industry's expected progress and is the primary driver in the global bioinformatics market.

The rise in demand for integrated data and the cost of sequencing decreases create growth opportunities for the market. Besides, the need for nucleic acid and protein sequencing will continue to increase, and increasing proteomics & genomics applications are positively impacting the market's growth. As a result, the global bioinformatics market is expected to grow significantly shortly. Government and private sector investments in the development of innovative products are expected to drive market growth during the forecast period.

The data storage and analysis application that can store large amounts of genomic and proteomic information and facilitate research activities from aging & carcinogenesis to the prevention and treatment of genetic diseases are anticipated to present growth opportunities for the market. Therefore, significant contributions to the development of the industry during the forecast period are also expected in the global bioinformatics market.

MARKET RESTRAINTS

The lack of skilled staff, standard data formats, easy-to-use tools available at bargain prices, and the inability to use the platform to integrate large datasets generated by bioinformatics is expected to hinder the bioinformatics market growth.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2023 to 2032

Base Year

2023

Forecast Period

2024 to 2032

Segments Covered

By Sector, Products & Services, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis; Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Market Leaders Profiled

Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc.

 

SEGMENTAL ANALYSIS

Global Bioinformatics Market By Sector

Based on the sector, the medical biotechnology segment is expected to account for the leading share in the global market during the forecast period due to the growing need to develop new drugs at low prices and the use of bioinformatics in pharmaceutical companies to develop drugs. In addition, bioinformatics has the two most traditional applications in the target drug discovery and validation process. Furthermore, the academic sector is also anticipated to grow at a healthy rate in the market during the forecast period due to the development institute's research and projects.

Global Bioinformatics Market By Products and Services

Based on products & services, the knowledge management tools segment is estimated to register the largest share in the global, on the other hand, market. Bioinformatics platforms are the fastest-growing sub-segment based on products & services.

The data analytics is estimated to showcase a robust CAGR from 2024 to 2029 due to the demand for high-performing sequencing data solutions. Furthermore, genetic sequencing is expected to have the fastest growth in the coming years due to rising awareness about genome and exome technologies because of low cost. 

Global Bioinformatics Market By Application

Based on the applications segment, Genomics accounts for the largest market share during the forecast period. The genomics application segment is grabbing growth in this market due to increasing the Application in gene sequencing. The proteomics segment is expected to grow in the coming years due to new technologies and several research projects in the bioinformatics market.

REGIONAL ANALYSIS

Regionally, the North American regional market is predicted to lead the global bioinformatics market, followed by Europe. However, Asia-Pacific is the fastest-growing market in the world. Factors like rising funding for research, growing demand for bioinformatics in proteomics and genomics research, and technological advancements are expected to drive the rise of this market.

The Bioinformatics market in the Asia Pacific will grow fastest, with double-digit expected growth from 2024 to 2032, thanks to the improved healthcare infrastructure and development plans adopted by regional pharmaceutical companies. It is expected to be accomplished. Many infectious disease patients are in the Asia-Pacific region, accelerating the market's demand. APAC accounts for 60% of the world's total population, so a low prevalence means many infected people. Emerging economies, such as India and Australia, also contribute to revenue sharing and progress elsewhere in the Asia-Pacific region. As service outsourcing gains momentum, an increasing number of Asian countries are participating in establishing infrastructure and are expected to influence sector revenue generation through government investment and academic innovation.

The Chinese bioinformatics market is expected to account for the largest share in this regional market during the forecast period due to modern healthcare infrastructure, growing perforation of cutting-edge research, and clinical laboratory techniques driving the bioinformatics market of this APAC region.

The Japanese market is another lucrative region in the Asia Pacific, filled with technological advancements and the growing decoding of genetic sequences. However, a shortage of skilled bioinformatics professionals, high cost, and interaction hamper the growth.

The European market has experienced stable growth in the recent past and is predicted to be the same throughout the forecast period. As a result, this regional market is forecasted to showcase a CAGR of 26.8% from 2024 to 2032. Germany is the fastest-growing market among different nations of Europe and is predicted to hike at a CAGR of 33.12% during the forecast period.

The Latin American region is projected to grow at a healthy CAGR of 16.2% between 2024 to 2032. This regional market was dominated by Brazil in 2023, with over 35%, followed by Mexico.

KEY MARKET PARTICIPANTS

Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., and major companies operating in the global bioinformatics market Qiagen N.V., Biomax Informatics Ag, DNAnexus, Inc. and Waters Corporation.

Several biotech companies and research institutes have taken the initiative to study gene sequencing to grow the bioinformatics market. Using rapid-friendly software such as RasMol and BALL that is used to detect toxicity before the drug discovery processing in the market is a factor that increases the growth of the global market.

MAJOR HAPPENINGS IN THIS MARKET IN THE RECENT PAST

  • In 2020, Roche purchased Stratos genomics to innovate into Roche nanopore sequencing, which combines the electronics and biological components for fast and low-cost diagnostic testing of DNA sequencing. 
  • In 2019, Qiagen joined N-of-one to develop clinical bioinformatics services for complex genomic data management. Also, it helps to expand their decision-support solutions with consideration of software, content, and services. It provides clinical trials matching services and an oncology database of patients to the organization.
  • In 2019, NEC acquired Oncommunity, an immune profiler that uses machine learning to sequence cancerous patients. The development will provide better cancer treatment in the global bioinformatics market.

DETAILED SEGMENTATION OF THE GLOBAL BIOINFORMATICS MARKET INCLUDED IN THIS REPORT

This research report on the global bioinformatics market has been segmented and sub-segmented based on the sector, products & services, application, and region.

By Sector

  • Animal Biotechnology
  • Environmental Biotechnology
    • Alternative Energy Sources
    • Waste Clean-Up/Bioremediation
    • Climate Change Studies
  • Agricultural Biotechnology
    • Crop Yield Improvement
    • Pest Resistance
    • Improvement of Plant Resistance
    • Biodiversity Informatics
    • Nutritional Quality Improvement
  • Forensic Biotechnology
  • Medical Biotechnology
    • Drug Development
    • Clinical Diagnostics
    • Molecular Medicine
      • Personalized Medicine
      • Preventive Medicine
    • Gene Therapy
    • Reproductive Biotechnology
  • Academics
  • Other Sectors

By Products and Services

  • Bioinformatics Platforms
    • Sequence Analysis Platforms
    • Sequence Alignment Platforms
    • Sequence Manipulation Platforms
    • Structural and Functional Analysis Platforms
    • Other Bioinformatics Platforms
  • Knowledge Management Tools
    • Generalized Knowledge Management Tools
    • Specialized Knowledge Management Tools
  • Bioinformatics Services
    • Data Analysis
    • Sequencing Services
    • Other Bioinformatics Services
    • Database and Management Services

By Application

  • Proteomics
  • Transcriptomics
  • Molecular Phylogenetics
  • Chemoinformatics
  • Drug Design
  • Genomics

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Frequently Asked Questions

How much is the global bioinformatics market going to be worth by 2032?

As per our research report, the global bioinformatics market size is estimated to grow to USD 77.21 billion by 2032.

Who are the major players operating in the bioinformatics market ?

Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Biomax Informatics Ag are some of the key market players in bioinformatics market.

At What CAGR, the global bioinformatics market is expected to grow from 2024 to 2032?

The global bioinformatics market is estimated to grow at a CAGR of 19.29% from 2024 to 2032.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample